check_circleStudy Completed

Contraception

Influence of estrogens on DRSP

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

18 - 35 Years
  • -

  • -

Trial summary

Enrollment Goal
83
Trial Dates
June 2010 - March 2011
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Angeliq (E2/DRSP, BAY86-4891)
Accepts Healthy Volunteer
N/A

Where to participate

StatusInstitutionLocation
Completed
Bayer Pharma AGBerlin, 13353, Germany
Completed
Dinox GmbH BerlinBerlin, 10115, Germany

Trial design

A two-center, 4-arm, open-label, randomized study in 80 healthy young women to investigate effects of co-administered estradiol (E2) and ethinylestradiol (EE) on the pharmacokinetics and -dynamics of drospirenone (DRSP) after oral single and multiple doses of three different combinations in comparison to drospirenone alone
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A